Terry Conrad

Terry Conrad is an accomplished professional with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Operating Partner at HealthEdge Investment Partners since December 2015, Terry has held several leadership roles, including President/CEO of Westone Laboratories from December 2019 to September 2023, and President/CEO of MNG Laboratories from February 2016 to March 2019. Prior positions include President/CEO of Santus Holdings/Santus LLC and President of Photocure Inc., where notable contributions included the establishment of U.S. operations. Terry has also served as Board Member at Advanced Bio-Technologies and held founding and leadership roles at Branthan Laboratories LLC and as Vice Chair of the Piedmont Triad Biotech Advisory Board. Terry holds an MS in Pharmaceutical Marketing from the University of Minnesota and a BS in Chemistry from Saint John's University.